Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)
Hong Kong
· Delayed Price · Currency is HKD 20.65
-0.90 (-4.18%)
Mar 3, 2025, 4:08 PM HKT
HKG:2252 Revenue
Shanghai MicroPort MedBot (Group) had revenue of 99.24M CNY in the half year ending June 30, 2024, with 9,369.18% growth. This brings the company's revenue in the last twelve months to 156.23M, up 129.21% year-over-year. In the year 2023, Shanghai MicroPort MedBot (Group) had annual revenue of 104.59M with 384.15% growth.
Revenue (ttm)
156.23M CNY
Revenue Growth
+129.21%
P/S Ratio
117.92
Revenue / Employee
241.84K CNY
Employees
646
Market Cap
20.78B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 104.59M | 82.99M | 384.15% |
| Dec 31, 2022 | 21.60M | 19.45M | 904.79% |
| Dec 31, 2021 | 2.15M | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 29.60B |
| JD Health International | 58.84B |
| Hansoh Pharmaceutical Group Company | 13.00B |
| WuXi Biologics | 18.39B |
| Alibaba Health Information Technology | 31.39B |
| Innovent Biologics | 8.01B |
| Akeso | 2.01B |
| Sinopharm Group | 634.32B |